Subscribe To
NRBO / Here's Why NeuroBo Pharmaceuticals, Inc. (NRBO) Could be Great Choice for a Bottom Fisher
NRBO News
By PRNewsWire
October 17, 2023
NeuroBo to Present at the H.C. Wainwright 7th Annual NASH Investor Conference
BOSTON , Oct. 17, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform ca more_horizontal
By Zacks Investment Research
June 6, 2023
Here's Why NeuroBo Pharmaceuticals, Inc. (NRBO) Could be Great Choice for a Bottom Fisher
NeuroBo Pharmaceuticals, Inc. (NRBO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In more_horizontal
By PennyStocks
November 10, 2022
Buying Biotech Penny Stocks? 3 Things to Look For
Are biotech penny stocks on your buy list right now The post Buying Biotech Penny Stocks? 3 Things to Look For appeared first on Penny Stocks to Buy more_horizontal
By PRNewsWire
October 5, 2021
NeuroBo Pharmaceuticals Closes $14 Million Registered Direct Offering
BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and more_horizontal
By PRNewsWire
October 5, 2021
NeuroBo Pharmaceuticals Closes $14 Million Registered Direct Offering
BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and more_horizontal
By PRNewsWire
October 5, 2021
NeuroBo Pharmaceuticals Closes $14 Million Registered Direct Offering
BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and more_horizontal
By PRNewsWire
October 5, 2021
NeuroBo Pharmaceuticals Closes $14 Million Registered Direct Offering
BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and more_horizontal
By PRNewsWire
October 5, 2021
NeuroBo Pharmaceuticals Closes $14 Million Registered Direct Offering
BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and more_horizontal